BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23303819)

  • 1. The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain.
    Smith KA; Pease RJ; Avery CA; Brown JM; Adamson PJ; Cooke EJ; Neergaard-Petersen S; Cordell PA; Ariëns RA; Fishwick CW; Philippou H; Grant PJ
    Blood; 2013 Mar; 121(11):2117-26. PubMed ID: 23303819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between factor XIII and the alphaC region of fibrinogen.
    Smith KA; Adamson PJ; Pease RJ; Brown JM; Balmforth AJ; Cordell PA; Ariëns RA; Philippou H; Grant PJ
    Blood; 2011 Mar; 117(12):3460-8. PubMed ID: 21224475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).
    Mouapi KN; Wagner LJ; Stephens CA; Hindi MM; Wilkey DW; Merchant ML; Maurer MC
    Thromb Haemost; 2019 Jul; 119(7):1048-1057. PubMed ID: 31055797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage.
    Mohammed RDS; Piell KM; Maurer MC
    Thromb Haemost; 2024 May; 124(5):408-422. PubMed ID: 38040030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
    Maurer MC; Trumbo TA; Isetti G; Turner BT
    Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.
    Souri M; Osaki T; Ichinose A
    J Biol Chem; 2015 May; 290(19):12027-39. PubMed ID: 25809477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
    Jadhav MA; Goldsberry WN; Zink SE; Lamb KN; Simmons KE; Riposo CM; Anokhin BA; Maurer MC
    Biochim Biophys Acta Proteins Proteom; 2017 Oct; 1865(10):1246-1254. PubMed ID: 28687225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between FXIII and fibrinogen.
    Kohler HP
    Blood; 2013 Mar; 121(11):1931-2. PubMed ID: 23493770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
    Standeven KF; Ariëns RA; Whitaker P; Ashcroft AE; Weisel JW; Grant PJ
    Diabetes; 2002 Jan; 51(1):189-97. PubMed ID: 11756340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbg αC 389-402 Enhances Factor XIII Cross-Linking in the Fibrinogen αC Region Via Electrostatic and Hydrophobic Interactions.
    Ablan FDO; Maurer MC
    Biochemistry; 2023 Jul; 62(14):2170-2181. PubMed ID: 37410946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment.
    Jadhav MA; Isetti G; Trumbo TA; Maurer MC
    Biochemistry; 2010 Apr; 49(13):2918-24. PubMed ID: 20218626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.
    Jadhav MA; Lucas RC; Goldsberry WN; Maurer MC
    Biochim Biophys Acta; 2011 Dec; 1814(12):1955-63. PubMed ID: 21798378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury.
    Poole LG; Kopec AK; Groeneveld DJ; Pant A; Baker KS; Cline-Fedewa HM; Flick MJ; Luyendyk JP
    Blood; 2021 May; 137(18):2520-2531. PubMed ID: 33569603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
    Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
    Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII: novel structural and functional aspects.
    Komáromi I; Bagoly Z; Muszbek L
    J Thromb Haemost; 2011 Jan; 9(1):9-20. PubMed ID: 20880254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation.
    Li B; Billur R; Maurer MC; Kohler HP; Raddatz Müller P; Alberio L; Schroeder V
    Thromb Haemost; 2018 Dec; 118(12):2037-2045. PubMed ID: 30419598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
    Isetti G; Maurer MC
    J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptospira Immunoglobulin-Like Protein B (LigB) Binds to Both the C-Terminal 23 Amino Acids of Fibrinogen αC Domain and Factor XIII: Insight into the Mechanism of LigB-Mediated Blockage of Fibrinogen α Chain Cross-Linking.
    Hsieh CL; Chang E; Tseng A; Ptak C; Wu LC; Su CL; McDonough SP; Lin YP; Chang YF
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004974. PubMed ID: 27622634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.